title: Rickettsialpox in North Carolina: a case report.
abstract: We report a case of rickettsialpox from North Carolina confirmed by serologic testing. To our knowledge, this case is the first to be reported from this region of the United States. Including rickettsialpox in the evaluation of patients with eschars or vesicular rashes is likely to extend the recognized geographic distribution of Rickettsia akari, the etiologic agent of this disease.
authors.affiliation: Infection Control and Hospital Epidemiology, Northeast Medical Center, Concord, North Carolina, USA.
authors.forename: Allan
authors.initials: A
authors.lastname: Krusell
authors.forename: James A
authors.initials: JA
authors.lastname: Comer
authors.forename: Daniel J
authors.initials: DJ
authors.lastname: Sexton
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D002437:Cefazolin / Q000627:therapeutic use; D002511:Cephalosporins / Q000627:therapeutic use; D004318:Doxycycline / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008875:Middle Aged; D009657:North Carolina / Q000453:epidemiology; D012287:Rickettsiaceae / Q000302:isolation & purification*; D012288:Rickettsiaceae Infections / Q000175:diagnosis* / Q000188:drug therapy / Q000453:epidemiology / Q000382:microbiology*; D012698:Serologic Tests
chemical_list: D000900:Anti-Bacterial Agents; D002511:Cephalosporins; D002437:Cefazolin; D004318:Doxycycline